Medinova Diagnostic Service Share Price Today | Stock Price & Medinova Diagnostic Service Share Screener
As of November 21, 2025, the live Medinova Diagnostic Service share price (BSE: MEDINOV) is ₹44.01, down 0.05% from the previous close, with shares trading between ₹43.51 and ₹45.10 in today's trading session, and a 52-week range of ₹38.55–₹44.54. Check MEDINOV price range for the annual price range and momentum. Use the Medinova Diagnostic Service stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medinova Diagnostic Service opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹3 and net income of ₹1, with EBITDA of ₹1, an operating margin of 33.0% and a profit margin of 33.3%.
Medinova Diagnostic Service Share Price Chart
Track the current stock price of Medinova Diagnostic Service with an interactive chart. Analyse MEDINOV share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medinova Diagnostic Service stock quote in one place.
The quote of ₹44.01 sits between the 52-week low of ₹38.55 and the 52-week high of ₹44.54, and the latest session moved -0.05% from the previous close.
Medinova Diagnostic Service Company Profile - Fundamental Screener
Screen Medinova Diagnostic Service company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDINOV shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE047C01019.
Company Details
Classification
Identifiers and Leadership
Medinova Diagnostic Service Balance Sheet Screener
Screen MEDINOV balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹7 against total liabilities of ₹7, up from ₹5 in 2024.
Latest statistics put total assets at ₹7 and shareholder funds at ₹-1.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 7 | 5 | 5 | 4 | 4 | 4 | 5 | 6 | 9 | 13 |
| Current Assets | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 5 | 7 | 9 |
Liabilities |
||||||||||
| Total Liabilities | 7 | 5 | 5 | 4 | 4 | 4 | 5 | 6 | 9 | 13 |
| Current Liabilities | 5 | 5 | 6 | 6 | 4 | 5 | 5 | 6 | 7 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | -1 | -3 | -5 | -7 | -8 | -9 | -9 | -10 | -10 | -8 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -11 | -13 | -15 | -17 | -17 | -19 | -19 | -20 | -20 | -18 |
Medinova Diagnostic Service Income Statement Screener - Profit & Revenue Analysis
Screen Medinova Diagnostic Service income statement and profit fundamentals. Analyze MEDINOV quarterly results. Medinova Diagnostic Service reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2025-Mar, revenue was ₹3 and net profit was ₹1, equal to earnings per unit of ₹0.60, at an operating margin of 33%.
In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2025-Jun, shows revenue of ₹3 and net profit of ₹1.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 2 |
| Expenses | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 33.00% | 39.00% | 37.00% | 30.00% | 28.00% | 31.00% | 29.00% | 33.00% | 22.00% | 32.00% | 25.00% | 26.00% | 24.00% | 24.00% | 22.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.60 | 0.66 | 0.52 | 0.60 | 0.42 | 0.50 | 0.38 | 0.78 | 0.33 | 0.67 | 0.40 | 0.35 | 0.30 | 0.36 | 0.24 |
Medinova Diagnostic Service Cash Flow Screener - Liquidity Fundamentals
Screen MEDINOV cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹3.
Over the same period, investing activities used ₹2 and financing activities used ₹1.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 3 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | -1 |
| Investing Activities | -2 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | -5 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | -1 | -1 | 0 | -1 | -1 | -1 | -2 | 0 | 5 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Medinova Diagnostic Service Shareholding Pattern Screener
See Medinova Diagnostic Service shareholding pattern with promoter, FII, and DII holdings. Check Medinova Diagnostic Service promoter holding and ownership changes for MEDINOV on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 62.14%, foreign institutions 0.00%, domestic institutions 0.00% and the public 35.97%, spread across 10,847 shareholders.
The shareholder count was 10,847 in 2025-Mar, compared with 10,750 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 62.14% | 62.14% | 62.14% | 62.14% | 62.14% | 62.14% | 62.14% | 62.14% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 35.97% | 35.52% | 34.96% | 35.58% | 36.09% | 36.29% | 35.90% | 35.94% |
| Other Holding | 1.89% | 2.35% | 2.90% | 2.28% | 1.77% | 1.58% | 1.97% | 1.93% |
| Shareholder Count | 10,847 | 10,750 | 10,609 | 10,295 | 10,544 | 10,730 | 10,931 | 9,926 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medinova Diagnostic Service. Medinova Diagnostic Service dividend yield can be compared with peers and other stocks in the market.
Medinova Diagnostic Service Stock Index Membership - Nifty & Sensex
See which indices include Medinova Diagnostic Service stock. Check MEDINOV index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Medinova Diagnostic Service Market Events Screener - Corporate Actions
Get Medinova Diagnostic Service corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medinova Diagnostic Service stock events that may affect MEDINOV share price, along with derivatives, futures and options activity and sector gainers.
8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2025, with a record date of November 3, 2025.
It is followed by Annual General Meeting dated September 3, 2025 and Quarterly Result Announcement dated July 26, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -2.52% |
| 2025-09-03 | 2025-09-03 | Annual General Meeting | NA | -0.37% |
| 2025-07-26 | 2025-07-26 | Quarterly Result Announcement | NA | 1.80% |
| 2025-05-03 | 2025-05-03 | Quarterly Result Announcement | NA | 2.75% |
| 2025-04-25 | 2025-04-25 | Extraordinary General Meeting | NA | 8.29% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -8.33% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.17% |
| 2024-09-03 | 2024-09-03 | Annual General Meeting | NA | 6.74% |
Medinova Diagnostic Service Competitors Screener - Peer Stocks Comparison
Screen MEDINOV competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 25,970 | 48.09 | 2,555 | 11.28% | 492 | 45.98 |
| Vijaya Diagnostic Centre | 10,337 | 69.16 | 700 | 23.06% | 144 | 56.20 |
| Metropolis Healthcare | 10,043 | 63.88 | 1,346 | 10.64% | 146 | 45.98 |
| Thyrocare Technologies | 7,294 | 58.36 | 702 | 20.80% | 91 | 64.18 |
| Krsnaa Diagnostics | 2,695 | 29.22 | 743 | 16.70% | 78 | 30.62 |
| Suraksha Diagnostic | 1,683 | 51.19 | 256 | 15.11% | 31 | 58.30 |
| 3B BlackBio DX | 1,156 | 23.26 | 112 | 28.72% | 48 | 40.06 |
| Sastasundar Ventures | 921 | -6.16 | 1,171 | -18.47% | -134 | 38.07 |
| One Global Service Provider | 834 | 29.66 | 148 | 134.60% | 19 | 74.75 |
| Choksi Laboratories | 98 | 66.31 | 42 | 13.28% | 2 | 32.99 |
Medinova Diagnostic Service Company Announcements - News & Reports Screener
Screen MEDINOV latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 29, 2026.
The next most recent announcements are dated September 29, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-29 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-09-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-29 | Corporate Action - Fixation Of Record Date On November 25 2025. | - |
| 2026-09-29 | Board Meeting Outcome for Held On 03Rd November 2025 | - |
| 2026-09-29 | Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | - |
| 2025-10-27 | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 03/11/2025 Inter Alia To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter And Half Year E | - |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2025-09-25 | Closure of Trading Window | - |
| 2025-09-24 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2025-09-03 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-08-12 | Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-08-11 | Reg. 34 (1) Annual Report. | - |
| 2025-08-11 | Notice Of 32Nd Annual General Meeting Of The Company | - |
| 2025-08-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-08-09 | Information Relating To 32Nd Annual General Meeting (AGM) | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹44.01, within a 52-week range of ₹38.55 to ₹44.54. The P/E ratio is 20.28 and the P/B ratio is -747.86, with earnings per unit of ₹1.89. Market capitalisation stands at ₹43.70 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.